Clinical Trial

The MIRIA Acne Scar Study

Study acronym: MIRIA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-10-24; most recent amendment 2025-03-05.
Status change: Recruiting → Active, Not Recruiting 2024-12-12
Trial Details
NCT Number NCT05597267
Lead Sponsor AVAVA, Inc.
Conditions Acne Scars - Mixed Atrophic and Hypertrophic
Enrollment 75 participants
Start Date 2022-11-04
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2025-03-07